Likelihood of Dupuytren Contracture Recurrence After Limited Fasciectomy, Needle Aponeurotomy or Collagenase Clostridium histolyticum: Systematic Review of Prospective Data With 2- to 7-Year Follow-up
Open Access
- 5 March 2026
- journal article
- review article
- Published by Elsevier in Journal of Hand Surgery Global Online
- Vol. 8 (3) , 100979
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Collagenase clostridium histolyticum injection versus limited fasciectomy for the treatment of Dupuytren’s disease: a systematic review and meta-analysis of comparative studiesArchives of orthopaedic and trauma surgery, 2023
- The End of an Era: Withdrawal of Xiapex (Clostridium histolyticum Collagenase) from the European MarketEuropean Urology, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Factors influencing recurrence and progression of Dupuytren’s disease treated by Collagenase Clostridium histolitycumInternational Orthopaedics, 2017
- Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up resultsHand Surgery and Rehabilitation, 2017
- The consequences of different definitions for recurrence of Dupuytren's diseaseJournal of Plastic, Reconstructive & Aesthetic Surgery, 2013
- A Systematic Review of Outcomes of Fasciotomy, Aponeurotomy, and Collagenase Treatments for Dupuytren's ContractureHAND, 2011
- Injectable Collagenase Clostridium Histolyticum: A New Nonsurgical Treatment for Dupuytren's DiseaseThe Journal of Hand Surgery, 2010
- Prevalence, Incidence, and Treatments of Dupuytren's Disease in the United States: Results from a Population-Based StudyHAND, 2010
- The Complications of Dupuytren’s Contracture SurgeryThe Journal of Hand Surgery, 2005